The Myeloma Masquerade: Diagnosing Multiple Myeloma in the Absence of Hypercalcemia and Bence Jones Proteinuria - A Case Report
Keywords:
Multiple myeloma, Osteolysis, Bortezomib, Plasma cell neoplasm, Case ReportAbstract
ABSTRACT.
BACKGROUND: Multiple myeloma is a malignant plasma cell disorder defined by clonal bone marrow infiltration, monoclonal immunoglobulin secretion, and end-organ damage affecting the skeletal, renal, and hematopoietic systems. Diagnosis may be delayed when atypical presentations lack hallmark features such as hypercalcemia or Bence Jones proteinuria, underscoring the need for a high clinical index of suspicion.
THE CASE: A 60-year-old male presented with a 15-day history of generalized weakness, and decreased appetite, with intermittent low back pain for six months. The pain was dull and aching, non-radiating, activity-aggravated, and worse at night. No fever, weight loss, trauma, urinary symptoms, or tuberculosis contact was reported. Past medical history was unremarkable.
On examination, the patient was conscious, oriented, and with pallor noted, with moderate build and nutrition. Vital signs were stable except for mild tachycardia (pulse 105/min) and blood pressure of 150/80 mmHg. Musculoskeletal assessment demonstrated thoracic kyphosis, scoliosis, and bony tenderness over the lumbar spine without focal neurological deficits. Differential diagnoses considered were multiple myeloma, spinal tuberculosis, and metastatic malignancy.
Investigations revealed severe normocytic normochromic anemia (hemoglobin 6.6 g/dL), elevated serum urea (64 mg/dL), mildly raised creatinine (1.46 mg/dL), markedly elevated total protein (11.6 g/dL) and globulin (8.01 g/dL), a low albumin-to-globulin ratio (0.44) and elevated alkaline phosphatase. Notably, serum calcium was within normal limits (9.8 mg/dL), and urine Bence Jones protein was negative - posing an initial diagnostic challenge. Peripheral smear and reticulocyte count were consistent with marrow pathology. MRI of the lumbosacral spine demonstrated diffuse osteoporosis, extensive osteolytic lesions, and vertebral height reduction suggestive of multiple myeloma.
Bone marrow aspiration revealed atypical plasma cells showing binucleation, multinucleation, flame cells, and occasional plasmablasts along with suppression of normal hematopoietic elements. Bone marrow biopsy confirmed sheets of plasma cells with plasmablastic forms, consistent with multiple myeloma. Serum protein electrophoresis demonstrated a monoclonal spike, and serum kappa light chains were significantly elevated (234.27 mg/L), establishing the diagnosis.
The patient was initiated on chemotherapy with weekly Bortezomib (1.3 mg/m2) and Thalidomide (100 mg daily), with prophylactic acyclovir, fluconazole, and allopurinol. Follow-up monitoring included complete blood count, renal function, peripheral neuropathy screening, and infection surveillance.
CONCLUSION: Multiple myeloma can present without classical features such as hypercalcemia or Bence Jones proteinuria. Clinicians should maintain heightened suspicion for multiple myeloma in elderly patients with persistent back pain, severe anemia, hyperglobulinemia, and osteolytic lesions. Early comprehensive diagnostic evaluation – including bone marrow biopsy, serum protein electrophoresis, and serum free light chain assay – is critical for timely diagnosis and treatment initiation.
References
1. Rajkumar SV, Dimopoulos MA, Palumbo A, et al. Lancet Oncol. 2014;15(12):e538–548.
2. Rajkumar SV. Am J Hematol. 2024;99(9):1802–1824.
3. Richardson PG, et al. N Engl J Med. 2005;352(24):2487–2498.
4. Dispenzieri A, et al. Leukemia. 2009;23(2):215–224.
Downloads
Published
How to Cite
License
Copyright (c) 2026 Mounasree, Anshu, Sasidhar Sureddi, Kalyan Kumar Galeti

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- The Author retains copyright in the Work, where the term “Work” shall include all digital objects that may result in subsequent electronic publication or distribution.
- Upon acceptance of the Work, the author shall grant to the Publisher the right of first publication of the Work.
- The Author shall grant to the Publisher and its agents the nonexclusive perpetual right and license to publish, archive, and make accessible the Work in whole or in part in all forms of media now or hereafter known under a Creative Commons Attribution 4.0 International License or its equivalent, which, for the avoidance of doubt, allows others to copy, distribute, and transmit the Work under the following conditions:
- Attribution—other users must attribute the Work in the manner specified by the author as indicated on the journal Web site; with the understanding that the above condition can be waived with permission from the Author and that where the Work or any of its elements is in the public domain under applicable law, that status is in no way affected by the license.
- The Author is able to enter into separate, additional contractual arrangements for the nonexclusive distribution of the journal's published version of the Work (e.g., post it to an institutional repository or publish it in a book), as long as there is provided in the document an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post online a prepublication manuscript (but not the Publisher’s final formatted PDF version of the Work) in institutional repositories or on their Websites prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work. Any such posting made before acceptance and publication of the Work shall be updated upon publication to include a reference to the Publisher-assigned DOI (Digital Object Identifier) and a link to the online abstract for the final published Work in the Journal.
- Upon Publisher’s request, the Author agrees to furnish promptly to Publisher, at the Author’s own expense, written evidence of the permissions, licenses, and consents for use of third-party material included within the Work, except as determined by Publisher to be covered by the principles of Fair Use.
- The Author represents and warrants that:
- the Work is the Author’s original work;
- the Author has not transferred, and will not transfer, exclusive rights in the Work to any third party;
- the Work is not pending review or under consideration by another publisher;
- the Work has not previously been published;
- the Work contains no misrepresentation or infringement of the Work or property of other authors or third parties; and
- the Work contains no libel, invasion of privacy, or other unlawful matter.
- The Author agrees to indemnify and hold Publisher harmless from the Author’s breach of the representations and warranties contained in Paragraph 6 above, as well as any claim or proceeding relating to Publisher’s use and publication of any content contained in the Work, including third-party content.
Enforcement of copyright
The IJMS takes the protection of copyright very seriously.
If the IJMS discovers that you have used its copyright materials in contravention of the license above, the IJMS may bring legal proceedings against you seeking reparation and an injunction to stop you using those materials. You could also be ordered to pay legal costs.
If you become aware of any use of the IJMS' copyright materials that contravenes or may contravene the license above, please report this by email to contact@ijms.org
Infringing material
If you become aware of any material on the website that you believe infringes your or any other person's copyright, please report this by email to contact@ijms.org



